NDRA

ENDRA Life Sciences Inc. [NDRA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NDRA Stock Summary

Top 10 Correlated ETFs

NDRA


Top 10 Correlated Stocks

NDRA


In the News

10:14 10 Dec 2023 NDRA

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2023 Results Conference Call November 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.

04:05 10 Dec 2023 NDRA

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three and nine months ended September 30, 2023 on Tuesday, November 14, 2023 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate d.

09:44 10 Dec 2023 NDRA

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

09:48 10 Dec 2023 NDRA

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Inc. First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

09:09 10 Dec 2023 NDRA

Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?

ENDRA Life Sciences (NASDAQ: NDRA ) stock is sliding lower on Friday after revealing details of its public offering. ENDRA Life Sciences is offering up 862,500 shares of NDRA stock alongside 431,250 warrants to purchase more shares.

07:31 10 Dec 2023 NDRA

ENDRA Life Sciences Inc. (NDRA) Q4 2022 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q4 2022 Earnings Conference Call March 14, 2023 4:30 PM ET Company Participants Yvonne Briggs – LHA Investor Relations Francois Michelon – Chairman and Chief Executive Officer Michael Thornton – Chief Technology Officer Irina Pestrikova – Senior Director-Finance Conference Call Participants Vernon Bernardino – H.C. Wainwright & Company Edward Woo – Ascendiant Capital Operator Good afternoon, and welcome to the ENDRA Life Sciences Incorporated Fourth Quarter 2022 Financial Results Conference Call.

04:05 10 Dec 2023 NDRA

ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and year ended December 31, 2022 on Tuesday, March 14, 2023 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m.

06:31 10 Dec 2023 NDRA

ENDRA Life Sciences Inc. (NDRA) Q3 2022 Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Yvonne Briggs - Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Renaud Maloberti - Chief Commercial Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode.

07:56 10 Dec 2023 NDRA

ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q2 2022 Results - Earnings Call Transcript

ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike Thornton - Chief Technology Officer Renaud Maloberti - CCO Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Vernon Bernardino - H.C. Wainwright Operator Good day everyone, and welcome to the ENDRA Life Sciences' Second Quarter 2022 Financial Results Conference Call.

07:09 10 Dec 2023 NDRA

Which Penny Stocks Are Investors Buying Right Now? 3 to Watch

Why investors are buying these penny stocks right now The post Which Penny Stocks Are Investors Buying Right Now? 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

NDRA Financial details

Company Rating
Neutral
Market Cap
12.68M
Income
-11.87M
Revenue
0
Book val./share
0.68
Cash/share
0.43
Dividend
-
Dividend %
-
Employees
21
Optionable
No
Shortable
Yes
Earnings
14 Nov 2023
P/E
-0.97
Forward P/E
-0.99
PEG
-0
P/S
-
P/B
2.22
P/C
3.49
P/FCF
-1.2
Quick Ratio
1.54
Current Ratio
2.95
Debt / Equity
0.08
LT Debt / Equity
0.05
-
-
EPS (TTM)
-1.09M
EPS next Y
-1.52
EPS next Q
-0.42
EPS this Y
-16.45%
EPS next Y
-100%
EPS next 5Y
-100%
EPS last 5Y
-36.28%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-6.98%
-
-
-
-
SMA20
26.04%
SMA50
9.01%
SMA100
-12.32%
Inst Own
0.02%
Inst Trans
2.48%
ROA
-156%
ROE
-199%
ROC
-2.28%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
8.45M
Shs Float
8.28M
-
-
-
-
Target Price
5
52W Range
0.87-5.95
52W High
-
52W Low
-
RSI
82.21
Rel Volume
1.51
Avg Volume
109.09K
Volume
164.63K
Perf Week
55.93%
Perf Month
54.64%
Perf Quarter
8.7%
Perf Half Y
-5.06%
-
-
-
-
Beta
1.183
-
-
Volatility
0.16%, 0.16%
Prev Close
8.7%
Price
1.5
Change
7.14%

NDRA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.030000
Net income per share
-43.49-41.48-12.47-5.47-4.57
Operating cash flow per share
-34.2-22.9-11.22-5.44-4.42
Free cash flow per share
-34.64-23.02-11.28-5.46-4.49
Cash per share
28.7316.467.534.621.69
Book value per share
27.7412.77.475.272.49
Tangible book value per share
27.7412.77.475.272.49
Share holders equity per share
27.7412.77.475.272.49
Interest debt per share
08.170.960.330.2
Market cap
6.76M12.6M14.39M28.32M11.77M
Enterprise value
285.92K7.13M7.85M19.54M7.43M
P/E ratio
-0.69-0.81-1.2-2.53-0.89
Price to sales ratio
1.09K0000
POCF ratio
-0.88-1.47-1.34-2.55-0.92
PFCF ratio
-0.87-1.46-1.33-2.54-0.91
P/B Ratio
1.082.652.012.631.63
PTB ratio
1.082.652.012.631.63
EV to sales
46.310000
Enterprise value over EBITDA
-0.03-0.66-0.69-1.73-0.57
EV to operating cash flow
-0.04-0.83-0.73-1.76-0.58
EV to free cash flow
-0.04-0.83-0.73-1.75-0.57
Earnings yield
-1.45-1.23-0.83-0.4-1.12
Free cash flow yield
-1.15-0.69-0.75-0.39-1.1
Debt to equity
00.150.10.060.08
Debt to assets
00.10.080.050.06
Net debt to EBITDA
0.770.50.580.780.34
Current ratio
7.133.158.327.835
Interest coverage
0-4.6-49.490-611.04
Income quality
0.790.650.920.990.97
Dividend Yield
00.330.0300
Payout ratio
0-0.27-0.03-0.010
Sales general and administrative to revenue
607.80000
Research and developement to revenue
764.90000
Intangibles to total assets
00000
Capex to operating cash flow
0.010.01000.02
Capex to revenue
-16.20000
Capex to depreciation
-1.46-0.38-0.31-0.2-0.86
Stock based compensation to revenue
00000
Graham number
164.76108.8545.7925.4716
ROIC
-1.33-2.16-1.43-0.95-1.59
Return on tangible assets
-1.36-2.17-1.37-0.87-1.42
Graham Net
25.0210.416.483.921.43
Working capital
5.97M4.46M7.23M10.55M6.82M
Tangible asset value
6.25M4.76M7.17M10.78M7.2M
Net current asset value
5.97M4.12M6.62M10M6.46M
Invested capital
00.150.10.060.08
Average receivables
76.14K131.09K253.77K195.4K0
Average payables
705.87K954.95K840.67K596.98K702.51K
Average inventory
125.56K86.44K351.53K937.1K1.96M
Days sales outstanding
8.6K0000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
0.040000
Payables turnover
00000
Inventory turnover
00000
ROE
-1.57-3.27-1.67-1.04-1.83
Capex per share
-0.44-0.12-0.05-0.02-0.07

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-1.1-1.09M-0.93-0.43-0.4
Operating cash flow per share
-1.03-1.03M-0.79-0.38-0.34
Free cash flow per share
-1.03-1.04M-0.8-0.38-0.34
Cash per share
2.541.63M0.740.80.43
Book value per share
3.232.4M1.421.160.68
Tangible book value per share
3.232.4M1.421.160.68
Share holders equity per share
3.232.4M1.421.160.68
Interest debt per share
0.19174.28K0.160.080.06
Market cap
19.33M12.217.26M8.39M8.53M
Enterprise value
11.9M-4.34M5.41M4.05M5.63M
P/E ratio
-1.40-0.62-0.82-0.69
Price to sales ratio
00000
POCF ratio
-5.950-2.89-3.7-3.28
PFCF ratio
-5.930-2.86-3.7-3.28
P/B Ratio
1.8901.611.211.64
PTB ratio
1.8901.611.211.64
EV to sales
00000
Enterprise value over EBITDA
-3.541.34-1.89-1.39-1.84
EV to operating cash flow
-3.661.41-2.16-1.78-2.17
EV to free cash flow
-3.651.39-2.14-1.78-2.17
Earnings yield
-0.18-267.47K-0.41-0.3-0.36
Free cash flow yield
-0.17-256.12K-0.35-0.27-0.3
Debt to equity
0.060.080.110.070.08
Debt to assets
0.050.060.080.050.06
Net debt to EBITDA
2.211.340.641.490.95
Current ratio
6.7853.013.982.95
Interest coverage
-148.5139.31-859.9600
Income quality
0.940.940.850.890.84
Dividend Yield
0221.21000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00.010.0100
Capex to revenue
00000
Capex to depreciation
-0.25-0.57-0.3800
Stock based compensation to revenue
00000
Graham number
8.937.67M5.453.332.48
ROIC
-0.3-0.4-0.54-0.38-0.52
Return on tangible assets
-0.28-0.35-0.44-0.28-0.41
Graham Net
2.281.38M0.490.650.3
Working capital
9.86M6.82M3.69M6.05M4.23M
Tangible asset value
10.2M7.2M4.5M6.93M5.2M
Net current asset value
9.43M6.46M3.36M5.77M3.99M
Invested capital
0.060.080.110.070.08
Average receivables
00000
Average payables
710.88K625.33K568.99K469.48K417.04K
Average inventory
2.5M2.64M2.69M2.75M2.76M
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.34-0.45-0.65-0.37-0.6
Capex per share
0-12.85K-0.0100

NDRA Frequently Asked Questions

What is ENDRA Life Sciences Inc. stock symbol ?

ENDRA Life Sciences Inc. is a US stock , located in Ann arbor of Mi and trading under the symbol NDRA

What is ENDRA Life Sciences Inc. stock quote today ?

ENDRA Life Sciences Inc. stock price is $1.5 today.

Is ENDRA Life Sciences Inc. stock public?

Yes, ENDRA Life Sciences Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap